Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer
Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Menon, Nandini, Chougule, Anuradha, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Kadam, Nandkumar, Daware, Nilesh, Bhattacharjee, Atanu, Shah, Srushti, Yadav, Akanksha, Trivedi, Vaishakhi, Behel, Vichitra, Dutt, Amit, Banavali, Shripad Dinanath, Prabhash, Kumar
Published in Journal of clinical oncology (10.01.2020)
Published in Journal of clinical oncology (10.01.2020)
Get full text
Journal Article
Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C)
Noronha, Vanita, Joshi, Amit, Patil, Vijay Maruti, Chougule, Anuradha, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Kadam, Nandkumar, Daware, Nilesh, Shah, Srushti, Yadav, Akanksha, Dutt, Amit, Trivedi, Vaishakhi, Behel, Vichitra, Banavali, Shripad Dinanath, Prabhash, Kumar
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article